ZSCAN5A

Across TCGA pan-cancer cohorts, ZSCAN5A Mutation is linked to patient survival in 5 of 34 cancer types, making it a survival-associated ZSCAN5A data layer compared with 25 for mass-spec protein.

The strongest signal is observed in uterine corpus endometrial carcinoma (UCEC), where higher ZSCAN5A Mutation is associated with better disease-free survival. In most high-consensus cancer types, elevated ZSCAN5A expression acts as an unfavorable survival marker, although some lineages such as UCEC show a favorable association.

UCEC, LUAD, and KIRC are the cancer types where ZSCAN5A Mutation most reproducibly stratifies survival.

Mutation survival associations by lineage

Ranked by sampling consensus. AUC1 and AUC2 indicate survival in the high- and low-expression groups, respectively; the lower AUC marks the poorer-surviving group. p-values are from the log-rank test.

Lineage	Measure	Split	Stage	AUC1 high	AUC2 low	p	Sampling consensus
UCEC	DFS	Median	All	1.000	0.628	.017	26	view →
LUAD	OS	Median	All	0.158	0.835	<.001	24	view →
KIRC	OS	Median	All	0.172	0.811	.002	18	view →
LUSC	DFS	Median	All	0.188	0.646	.009	12	view →
HNSC	OS	Median	II,III,IV	0.124	0.399	.033	4	view →

Pink = unfavorable, green = favorable. Showing the 5 strongest of 5 lineages.

ZSCAN5A–UCEC (DFS)

Open the UCEC breakdown →